CONTEMPORARY IDENTITY FOR BIOTECH COMPANIES
who we are discover
We are a Berlin-based creative collective with a full range of design services tailor-made for the biotech, science, and technology sectors. Our creative experts help you to develop a visual strategy to present your story or idea to the public, press, investors, and partners. Accurate and understandable visual communication and cutting-edge design thinking, that’s Biotech Design.
what we do our services
We already partnered with companies all around the world to develop their branding and help them roll out both print and online materials.
Cohesive visual identity
for your brand since logo,
stationery, deck presentations,
brochures and manuals.
Creation of press kit, advertising, flyer, banner, set design for booths, and signage that matches your concept.
User Experience, Interface
Design, SEO, e-commerce to create beautiful and engaging
Develop dynamic elements to bring your process to life, as personalized motion graphics and video editing.
how it works the process is simple
With our design wisdom and scientific advisors, we understand the needs of your dynamic industry and work with you to highlight the core of what sets your message apart.
Our partnership is the key to the success
our portfolio take a look
Here are some of the companies that our team already had the pleasure to design for:
our team nice to meet you
Founder + CEO. Specialist in contemporary communication and visual information, with 20 years of experience in graphic design for both web and print.
Account Head. Yale graduate, BA in history of science and history of medicine. Former Institute for Health Metrics and Evaluation fellow. Extensive copywriting experience for global clients.
Board Advisor. Medical doctor, graduated 2007. Member of the Clinical Staff and Dermatologist, Paulistano Hospital.
journal get inspired
A selection of news and upcoming events related to science, technology, and design that inspires positive change.
April 29, 2021
Effect of COVID-19 Antiviral Remdesivir Multiplied 10-Fold by Hepatitis C Drugs